WallStreetZenWallStreetZen

NASDAQ: IMCR
Immunocore Holdings PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IMCR

Based on 6 analysts offering 12 month price targets for Immunocore Holdings PLC

Min Forecast
$33.00-0.18%
Avg Forecast
$62.50+89.05%
Max Forecast
$100.00+202.48%

Should I buy or sell IMCR stock?

Based on 6 analysts offering ratings for Immunocore Holdings PLC.

Buy
Strong Buy
1 analysts 16.67%
Buy
3 analysts 50%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IMCR's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates IMCR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their IMCR stock forecasts and price targets.

IMCR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-02
lockedlocked$00.00+00.00%2025-05-08
lockedlocked$00.00+00.00%2025-04-14
lockedlocked$00.00+00.00%2025-04-10
lockedlocked$00.00+00.00%2025-04-07
Morgan Stanley
Bottom 8%
8
HoldAssumes$35.00+5.87%2025-03-07

1 of 1

Forecast return on equity

Is IMCR forecast to generate an efficient return?

Company
43%
Industry
119.29%
Market
-46.52%
IMCR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IMCR forecast to generate an efficient return on assets?

Company
15.83%
Industry
46.9%
IMCR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IMCR earnings per share forecast

What is IMCR's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.71
Avg 2 year Forecast
-$1.02
Avg 3 year Forecast
-$0.86

IMCR revenue forecast

What is IMCR's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$393.2M+17.88%
Avg 2 year Forecast
$430.5M+29.05%
Avg 3 year Forecast
$513.0M+53.78%
IMCR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IMCR revenue growth forecast

How is IMCR forecast to perform vs Biotechnology companies and vs the US market?

Company
14.64%
Industry
79.97%
Market
10.99%
IMCR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMCR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMCR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMCR$33.06$62.50+89.05%Buy
CLDX$24.94$45.20+81.23%Strong Buy
COGT$11.71$20.25+72.93%Strong Buy
TVTX$18.23$34.70+90.35%Strong Buy
AUPH$12.09$13.00+7.53%Buy
View Top Biotech Stocks

Immunocore Holdings Stock Forecast FAQ

Is Immunocore Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: IMCR) stock is to Buy IMCR stock.

Out of 6 analysts, 1 (16.67%) are recommending IMCR as a Strong Buy, 3 (50%) are recommending IMCR as a Buy, 2 (33.33%) are recommending IMCR as a Hold, 0 (0%) are recommending IMCR as a Sell, and 0 (0%) are recommending IMCR as a Strong Sell.

If you're new to stock investing, here's how to buy Immunocore Holdings stock.

What is IMCR's earnings growth forecast for 2025-2027?

(NASDAQ: IMCR) Immunocore Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.25%.

Immunocore Holdings's earnings in 2025 is -$21,628,000.On average, 8 Wall Street analysts forecast IMCR's earnings for 2025 to be -$35,479,998, with the lowest IMCR earnings forecast at -$70,829,389, and the highest IMCR earnings forecast at -$1,004,672. On average, 8 Wall Street analysts forecast IMCR's earnings for 2026 to be -$51,112,697, with the lowest IMCR earnings forecast at -$116,039,637, and the highest IMCR earnings forecast at $14,065,411.

In 2027, IMCR is forecast to generate -$43,075,320 in earnings, with the lowest earnings forecast at -$145,175,130 and the highest earnings forecast at $56,261,642.

What is IMCR's revenue growth forecast for 2025-2027?

(NASDAQ: IMCR) Immunocore Holdings's forecast annual revenue growth rate of 14.64% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 79.97%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.99%.

Immunocore Holdings's revenue in 2025 is $333,581,000.On average, 6 Wall Street analysts forecast IMCR's revenue for 2025 to be $19,752,508,096, with the lowest IMCR revenue forecast at $19,148,951,284, and the highest IMCR revenue forecast at $20,171,305,694. On average, 6 Wall Street analysts forecast IMCR's revenue for 2026 to be $21,624,614,236, with the lowest IMCR revenue forecast at $19,986,245,078, and the highest IMCR revenue forecast at $23,550,520,571.

In 2027, IMCR is forecast to generate $25,769,439,548 in revenue, with the lowest revenue forecast at $23,424,936,549 and the highest revenue forecast at $29,115,399,776.

What is IMCR's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: IMCR) forecast ROA is 15.83%, which is lower than the forecast US Biotechnology industry average of 46.9%.

What is IMCR's Price Target?

According to 6 Wall Street analysts that have issued a 1 year IMCR price target, the average IMCR price target is $62.50, with the highest IMCR stock price forecast at $100.00 and the lowest IMCR stock price forecast at $33.00.

On average, Wall Street analysts predict that Immunocore Holdings's share price could reach $62.50 by Jun 2, 2026. The average Immunocore Holdings stock price prediction forecasts a potential upside of 89.05% from the current IMCR share price of $33.06.

What is IMCR's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: IMCR) Immunocore Holdings's current Earnings Per Share (EPS) is -$0.43. On average, analysts forecast that IMCR's EPS will be -$0.71 for 2025, with the lowest EPS forecast at -$1.41, and the highest EPS forecast at -$0.02. On average, analysts forecast that IMCR's EPS will be -$1.02 for 2026, with the lowest EPS forecast at -$2.31, and the highest EPS forecast at $0.28. In 2027, IMCR's EPS is forecast to hit -$0.86 (min: -$2.89, max: $1.12).

What is IMCR's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: IMCR) forecast ROE is 43%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.